nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—CYP3A7—Sorafenib—thyroid cancer	0.157	0.27	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.157	0.27	CbGbCtD
Eplerenone—CYP3A5—Sorafenib—thyroid cancer	0.118	0.202	CbGbCtD
Eplerenone—CYP3A4—Vandetanib—thyroid cancer	0.0761	0.131	CbGbCtD
Eplerenone—CYP3A4—Sorafenib—thyroid cancer	0.0459	0.0789	CbGbCtD
Eplerenone—CYP3A4—Doxorubicin—thyroid cancer	0.0278	0.0479	CbGbCtD
Eplerenone—Myocardial infarction—Sorafenib—thyroid cancer	0.00172	0.00414	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00172	0.00414	CcSEcCtD
Eplerenone—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00166	0.004	CcSEcCtD
Eplerenone—Infection—Vandetanib—thyroid cancer	0.00165	0.00397	CcSEcCtD
Eplerenone—Nervous system disorder—Vandetanib—thyroid cancer	0.00162	0.00392	CcSEcCtD
Eplerenone—Skin disorder—Vandetanib—thyroid cancer	0.00161	0.00388	CcSEcCtD
Eplerenone—Vaginal haemorrhage—Epirubicin—thyroid cancer	0.00156	0.00377	CcSEcCtD
Eplerenone—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00156	0.00377	CcSEcCtD
Eplerenone—Urinary tract disorder—Sorafenib—thyroid cancer	0.00155	0.00375	CcSEcCtD
Eplerenone—Albuminuria—Epirubicin—thyroid cancer	0.00155	0.00374	CcSEcCtD
Eplerenone—Connective tissue disorder—Sorafenib—thyroid cancer	0.00155	0.00373	CcSEcCtD
Eplerenone—Urethral disorder—Sorafenib—thyroid cancer	0.00154	0.00372	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00151	0.00364	CcSEcCtD
Eplerenone—Insomnia—Vandetanib—thyroid cancer	0.0015	0.00361	CcSEcCtD
Eplerenone—Dyspnoea—Vandetanib—thyroid cancer	0.00148	0.00356	CcSEcCtD
Eplerenone—Tinnitus—Sorafenib—thyroid cancer	0.00147	0.00354	CcSEcCtD
Eplerenone—Flushing—Sorafenib—thyroid cancer	0.00146	0.00352	CcSEcCtD
Eplerenone—Cardiac disorder—Sorafenib—thyroid cancer	0.00146	0.00352	CcSEcCtD
Eplerenone—Dyspepsia—Vandetanib—thyroid cancer	0.00146	0.00352	CcSEcCtD
Eplerenone—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00145	0.00349	CcSEcCtD
Eplerenone—Vaginal haemorrhage—Doxorubicin—thyroid cancer	0.00145	0.00349	CcSEcCtD
Eplerenone—Albuminuria—Doxorubicin—thyroid cancer	0.00143	0.00346	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00143	0.00345	CcSEcCtD
Eplerenone—Fatigue—Vandetanib—thyroid cancer	0.00143	0.00344	CcSEcCtD
Eplerenone—Angiopathy—Sorafenib—thyroid cancer	0.00143	0.00344	CcSEcCtD
Eplerenone—Mediastinal disorder—Sorafenib—thyroid cancer	0.00142	0.00342	CcSEcCtD
Eplerenone—Pain—Vandetanib—thyroid cancer	0.00142	0.00342	CcSEcCtD
Eplerenone—Constipation—Vandetanib—thyroid cancer	0.00142	0.00342	CcSEcCtD
Eplerenone—Mental disorder—Sorafenib—thyroid cancer	0.00138	0.00332	CcSEcCtD
Eplerenone—Malnutrition—Sorafenib—thyroid cancer	0.00137	0.0033	CcSEcCtD
Eplerenone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00135	0.00327	CcSEcCtD
Eplerenone—Breast pain—Epirubicin—thyroid cancer	0.00133	0.0032	CcSEcCtD
Eplerenone—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00132	0.00318	CcSEcCtD
Eplerenone—Muscle spasms—Sorafenib—thyroid cancer	0.00132	0.00317	CcSEcCtD
Eplerenone—Abdominal pain—Vandetanib—thyroid cancer	0.00131	0.00316	CcSEcCtD
Eplerenone—Body temperature increased—Vandetanib—thyroid cancer	0.00131	0.00316	CcSEcCtD
Eplerenone—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00127	0.00307	CcSEcCtD
Eplerenone—Anaemia—Sorafenib—thyroid cancer	0.00127	0.00305	CcSEcCtD
Eplerenone—Angioedema—Sorafenib—thyroid cancer	0.00125	0.00302	CcSEcCtD
Eplerenone—Hyperuricaemia—Epirubicin—thyroid cancer	0.00125	0.00301	CcSEcCtD
Eplerenone—Syncope—Sorafenib—thyroid cancer	0.00123	0.00296	CcSEcCtD
Eplerenone—Breast pain—Doxorubicin—thyroid cancer	0.00123	0.00296	CcSEcCtD
Eplerenone—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00122	0.00294	CcSEcCtD
Eplerenone—Creatinine increased—Epirubicin—thyroid cancer	0.00122	0.00293	CcSEcCtD
Eplerenone—Loss of consciousness—Sorafenib—thyroid cancer	0.0012	0.0029	CcSEcCtD
Eplerenone—Cough—Sorafenib—thyroid cancer	0.00119	0.00288	CcSEcCtD
Eplerenone—Asthenia—Vandetanib—thyroid cancer	0.00119	0.00287	CcSEcCtD
Eplerenone—Blood uric acid increased—Epirubicin—thyroid cancer	0.00118	0.00284	CcSEcCtD
Eplerenone—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00118	0.00284	CcSEcCtD
Eplerenone—Pruritus—Vandetanib—thyroid cancer	0.00117	0.00283	CcSEcCtD
Eplerenone—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00117	0.00282	CcSEcCtD
Eplerenone—Myalgia—Sorafenib—thyroid cancer	0.00117	0.00281	CcSEcCtD
Eplerenone—Arthralgia—Sorafenib—thyroid cancer	0.00117	0.00281	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00116	0.00279	CcSEcCtD
Eplerenone—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00116	0.00279	CcSEcCtD
Eplerenone—Hyperuricaemia—Doxorubicin—thyroid cancer	0.00115	0.00278	CcSEcCtD
Eplerenone—Hyperkalaemia—Epirubicin—thyroid cancer	0.00114	0.00274	CcSEcCtD
Eplerenone—Diarrhoea—Vandetanib—thyroid cancer	0.00113	0.00273	CcSEcCtD
Eplerenone—Creatinine increased—Doxorubicin—thyroid cancer	0.00113	0.00271	CcSEcCtD
Eplerenone—Influenza like illness—Epirubicin—thyroid cancer	0.00112	0.00271	CcSEcCtD
Eplerenone—Infection—Sorafenib—thyroid cancer	0.00111	0.00268	CcSEcCtD
Eplerenone—Shock—Sorafenib—thyroid cancer	0.0011	0.00265	CcSEcCtD
Eplerenone—Nervous system disorder—Sorafenib—thyroid cancer	0.0011	0.00264	CcSEcCtD
Eplerenone—Dizziness—Vandetanib—thyroid cancer	0.0011	0.00264	CcSEcCtD
Eplerenone—Blood urea increased—Epirubicin—thyroid cancer	0.00109	0.00263	CcSEcCtD
Eplerenone—Blood uric acid increased—Doxorubicin—thyroid cancer	0.00109	0.00263	CcSEcCtD
Eplerenone—Skin disorder—Sorafenib—thyroid cancer	0.00109	0.00262	CcSEcCtD
Eplerenone—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00108	0.00261	CcSEcCtD
Eplerenone—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00107	0.00258	CcSEcCtD
Eplerenone—Vomiting—Vandetanib—thyroid cancer	0.00105	0.00254	CcSEcCtD
Eplerenone—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00105	0.00254	CcSEcCtD
Eplerenone—Rash—Vandetanib—thyroid cancer	0.00104	0.00252	CcSEcCtD
Eplerenone—Dermatitis—Vandetanib—thyroid cancer	0.00104	0.00252	CcSEcCtD
Eplerenone—Influenza like illness—Doxorubicin—thyroid cancer	0.00104	0.00251	CcSEcCtD
Eplerenone—Headache—Vandetanib—thyroid cancer	0.00104	0.0025	CcSEcCtD
Eplerenone—Pulmonary oedema—Epirubicin—thyroid cancer	0.00103	0.00248	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00102	0.00245	CcSEcCtD
Eplerenone—Blood urea increased—Doxorubicin—thyroid cancer	0.00101	0.00244	CcSEcCtD
Eplerenone—Dyspnoea—Sorafenib—thyroid cancer	0.000996	0.0024	CcSEcCtD
Eplerenone—Nausea—Vandetanib—thyroid cancer	0.000984	0.00237	CcSEcCtD
Eplerenone—Dyspepsia—Sorafenib—thyroid cancer	0.000984	0.00237	CcSEcCtD
Eplerenone—Diabetes mellitus—Epirubicin—thyroid cancer	0.000966	0.00233	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000965	0.00233	CcSEcCtD
Eplerenone—Fatigue—Sorafenib—thyroid cancer	0.000963	0.00232	CcSEcCtD
Eplerenone—Constipation—Sorafenib—thyroid cancer	0.000956	0.0023	CcSEcCtD
Eplerenone—Pain—Sorafenib—thyroid cancer	0.000956	0.0023	CcSEcCtD
Eplerenone—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000953	0.0023	CcSEcCtD
Eplerenone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000914	0.0022	CcSEcCtD
Eplerenone—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000894	0.00216	CcSEcCtD
Eplerenone—Body temperature increased—Sorafenib—thyroid cancer	0.000883	0.00213	CcSEcCtD
Eplerenone—Abdominal pain—Sorafenib—thyroid cancer	0.000883	0.00213	CcSEcCtD
Eplerenone—Renal impairment—Epirubicin—thyroid cancer	0.000883	0.00213	CcSEcCtD
Eplerenone—Hyponatraemia—Epirubicin—thyroid cancer	0.000844	0.00203	CcSEcCtD
Eplerenone—Renal impairment—Doxorubicin—thyroid cancer	0.000817	0.00197	CcSEcCtD
Eplerenone—Asthenia—Sorafenib—thyroid cancer	0.000802	0.00193	CcSEcCtD
Eplerenone—Pruritus—Sorafenib—thyroid cancer	0.000791	0.00191	CcSEcCtD
Eplerenone—Blood creatinine increased—Epirubicin—thyroid cancer	0.000787	0.0019	CcSEcCtD
Eplerenone—Dehydration—Epirubicin—thyroid cancer	0.000781	0.00188	CcSEcCtD
Eplerenone—Hyponatraemia—Doxorubicin—thyroid cancer	0.000781	0.00188	CcSEcCtD
Eplerenone—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000767	0.00185	CcSEcCtD
Eplerenone—Hypokalaemia—Epirubicin—thyroid cancer	0.000765	0.00184	CcSEcCtD
Eplerenone—Diarrhoea—Sorafenib—thyroid cancer	0.000765	0.00184	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000757	0.00182	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000741	0.00179	CcSEcCtD
Eplerenone—Dizziness—Sorafenib—thyroid cancer	0.000739	0.00178	CcSEcCtD
Eplerenone—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000728	0.00176	CcSEcCtD
Eplerenone—Dehydration—Doxorubicin—thyroid cancer	0.000723	0.00174	CcSEcCtD
Eplerenone—Eosinophilia—Epirubicin—thyroid cancer	0.000719	0.00173	CcSEcCtD
Eplerenone—Vomiting—Sorafenib—thyroid cancer	0.00071	0.00171	CcSEcCtD
Eplerenone—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00071	0.00171	CcSEcCtD
Eplerenone—Hypokalaemia—Doxorubicin—thyroid cancer	0.000708	0.00171	CcSEcCtD
Eplerenone—Angina pectoris—Epirubicin—thyroid cancer	0.000707	0.00171	CcSEcCtD
Eplerenone—Rash—Sorafenib—thyroid cancer	0.000705	0.0017	CcSEcCtD
Eplerenone—Dermatitis—Sorafenib—thyroid cancer	0.000704	0.0017	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.0007	0.00169	CcSEcCtD
Eplerenone—Headache—Sorafenib—thyroid cancer	0.0007	0.00169	CcSEcCtD
Eplerenone—Bronchitis—Epirubicin—thyroid cancer	0.000698	0.00168	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000686	0.00165	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000675	0.00163	CcSEcCtD
Eplerenone—Eosinophilia—Doxorubicin—thyroid cancer	0.000665	0.0016	CcSEcCtD
Eplerenone—Nausea—Sorafenib—thyroid cancer	0.000664	0.0016	CcSEcCtD
Eplerenone—Hyperglycaemia—Epirubicin—thyroid cancer	0.000655	0.00158	CcSEcCtD
Eplerenone—Angina pectoris—Doxorubicin—thyroid cancer	0.000655	0.00158	CcSEcCtD
Eplerenone—Pneumonia—Epirubicin—thyroid cancer	0.000651	0.00157	CcSEcCtD
Eplerenone—Infestation NOS—Epirubicin—thyroid cancer	0.000647	0.00156	CcSEcCtD
Eplerenone—Infestation—Epirubicin—thyroid cancer	0.000647	0.00156	CcSEcCtD
Eplerenone—Bronchitis—Doxorubicin—thyroid cancer	0.000646	0.00156	CcSEcCtD
Eplerenone—Renal failure—Epirubicin—thyroid cancer	0.000636	0.00153	CcSEcCtD
Eplerenone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000635	0.00153	CcSEcCtD
Eplerenone—Urinary tract infection—Epirubicin—thyroid cancer	0.000629	0.00152	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000624	0.00151	CcSEcCtD
Eplerenone—Haematuria—Epirubicin—thyroid cancer	0.000617	0.00149	CcSEcCtD
Eplerenone—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000612	0.00148	CcSEcCtD
Eplerenone—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000606	0.00146	CcSEcCtD
Eplerenone—Pneumonia—Doxorubicin—thyroid cancer	0.000603	0.00145	CcSEcCtD
Eplerenone—Infestation NOS—Doxorubicin—thyroid cancer	0.000599	0.00144	CcSEcCtD
Eplerenone—Infestation—Doxorubicin—thyroid cancer	0.000599	0.00144	CcSEcCtD
Eplerenone—Renal failure—Doxorubicin—thyroid cancer	0.000589	0.00142	CcSEcCtD
Eplerenone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000587	0.00142	CcSEcCtD
Eplerenone—Urinary tract infection—Doxorubicin—thyroid cancer	0.000582	0.0014	CcSEcCtD
Eplerenone—Hypoaesthesia—Epirubicin—thyroid cancer	0.000578	0.00139	CcSEcCtD
Eplerenone—Pharyngitis—Epirubicin—thyroid cancer	0.000577	0.00139	CcSEcCtD
Eplerenone—Urinary tract disorder—Epirubicin—thyroid cancer	0.000574	0.00138	CcSEcCtD
Eplerenone—Oedema peripheral—Epirubicin—thyroid cancer	0.000573	0.00138	CcSEcCtD
Eplerenone—Haematuria—Doxorubicin—thyroid cancer	0.000571	0.00138	CcSEcCtD
Eplerenone—Connective tissue disorder—Epirubicin—thyroid cancer	0.000571	0.00138	CcSEcCtD
Eplerenone—Urethral disorder—Epirubicin—thyroid cancer	0.00057	0.00137	CcSEcCtD
Eplerenone—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000567	0.00137	CcSEcCtD
Eplerenone—Tinnitus—Epirubicin—thyroid cancer	0.000542	0.00131	CcSEcCtD
Eplerenone—Flushing—Epirubicin—thyroid cancer	0.000539	0.0013	CcSEcCtD
Eplerenone—Cardiac disorder—Epirubicin—thyroid cancer	0.000539	0.0013	CcSEcCtD
Eplerenone—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000535	0.00129	CcSEcCtD
Eplerenone—Pharyngitis—Doxorubicin—thyroid cancer	0.000534	0.00129	CcSEcCtD
Eplerenone—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000531	0.00128	CcSEcCtD
Eplerenone—Oedema peripheral—Doxorubicin—thyroid cancer	0.00053	0.00128	CcSEcCtD
Eplerenone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000529	0.00127	CcSEcCtD
Eplerenone—Angiopathy—Epirubicin—thyroid cancer	0.000527	0.00127	CcSEcCtD
Eplerenone—Urethral disorder—Doxorubicin—thyroid cancer	0.000527	0.00127	CcSEcCtD
Eplerenone—Mediastinal disorder—Epirubicin—thyroid cancer	0.000524	0.00126	CcSEcCtD
Eplerenone—Mental disorder—Epirubicin—thyroid cancer	0.000509	0.00123	CcSEcCtD
Eplerenone—Malnutrition—Epirubicin—thyroid cancer	0.000506	0.00122	CcSEcCtD
Eplerenone—Tinnitus—Doxorubicin—thyroid cancer	0.000501	0.00121	CcSEcCtD
Eplerenone—Flushing—Doxorubicin—thyroid cancer	0.000499	0.0012	CcSEcCtD
Eplerenone—Cardiac disorder—Doxorubicin—thyroid cancer	0.000499	0.0012	CcSEcCtD
Eplerenone—Flatulence—Epirubicin—thyroid cancer	0.000499	0.0012	CcSEcCtD
Eplerenone—Back pain—Epirubicin—thyroid cancer	0.000489	0.00118	CcSEcCtD
Eplerenone—Angiopathy—Doxorubicin—thyroid cancer	0.000488	0.00118	CcSEcCtD
Eplerenone—Muscle spasms—Epirubicin—thyroid cancer	0.000486	0.00117	CcSEcCtD
Eplerenone—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000485	0.00117	CcSEcCtD
Eplerenone—Mental disorder—Doxorubicin—thyroid cancer	0.000471	0.00114	CcSEcCtD
Eplerenone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000469	0.00113	CcSEcCtD
Eplerenone—Malnutrition—Doxorubicin—thyroid cancer	0.000468	0.00113	CcSEcCtD
Eplerenone—Anaemia—Epirubicin—thyroid cancer	0.000468	0.00113	CcSEcCtD
Eplerenone—Flatulence—Doxorubicin—thyroid cancer	0.000461	0.00111	CcSEcCtD
Eplerenone—Malaise—Epirubicin—thyroid cancer	0.000456	0.0011	CcSEcCtD
Eplerenone—Syncope—Epirubicin—thyroid cancer	0.000454	0.00109	CcSEcCtD
Eplerenone—Back pain—Doxorubicin—thyroid cancer	0.000453	0.00109	CcSEcCtD
Eplerenone—Muscle spasms—Doxorubicin—thyroid cancer	0.00045	0.00109	CcSEcCtD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.000446	0.111	CbGpPWpGaD
Eplerenone—Loss of consciousness—Epirubicin—thyroid cancer	0.000445	0.00107	CcSEcCtD
Eplerenone—Cough—Epirubicin—thyroid cancer	0.000442	0.00106	CcSEcCtD
Eplerenone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000434	0.00105	CcSEcCtD
Eplerenone—Anaemia—Doxorubicin—thyroid cancer	0.000433	0.00104	CcSEcCtD
Eplerenone—Arthralgia—Epirubicin—thyroid cancer	0.000431	0.00104	CcSEcCtD
Eplerenone—Chest pain—Epirubicin—thyroid cancer	0.000431	0.00104	CcSEcCtD
Eplerenone—Myalgia—Epirubicin—thyroid cancer	0.000431	0.00104	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000428	0.00103	CcSEcCtD
Eplerenone—Discomfort—Epirubicin—thyroid cancer	0.000426	0.00103	CcSEcCtD
Eplerenone—Malaise—Doxorubicin—thyroid cancer	0.000422	0.00102	CcSEcCtD
Eplerenone—NR3C2—Preimplantation Embryo—NKX2-1—thyroid cancer	0.000422	0.105	CbGpPWpGaD
Eplerenone—Syncope—Doxorubicin—thyroid cancer	0.00042	0.00101	CcSEcCtD
Eplerenone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000411	0.000992	CcSEcCtD
Eplerenone—Infection—Epirubicin—thyroid cancer	0.00041	0.000989	CcSEcCtD
Eplerenone—Cough—Doxorubicin—thyroid cancer	0.000409	0.000985	CcSEcCtD
Eplerenone—Shock—Epirubicin—thyroid cancer	0.000406	0.00098	CcSEcCtD
Eplerenone—Nervous system disorder—Epirubicin—thyroid cancer	0.000405	0.000976	CcSEcCtD
Eplerenone—Skin disorder—Epirubicin—thyroid cancer	0.000401	0.000967	CcSEcCtD
Eplerenone—Hyperhidrosis—Epirubicin—thyroid cancer	0.000399	0.000963	CcSEcCtD
Eplerenone—Arthralgia—Doxorubicin—thyroid cancer	0.000399	0.000961	CcSEcCtD
Eplerenone—Chest pain—Doxorubicin—thyroid cancer	0.000399	0.000961	CcSEcCtD
Eplerenone—Myalgia—Doxorubicin—thyroid cancer	0.000399	0.000961	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000396	0.000954	CcSEcCtD
Eplerenone—Discomfort—Doxorubicin—thyroid cancer	0.000394	0.00095	CcSEcCtD
Eplerenone—Hypotension—Epirubicin—thyroid cancer	0.000386	0.00093	CcSEcCtD
Eplerenone—Infection—Doxorubicin—thyroid cancer	0.00038	0.000915	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000376	0.000907	CcSEcCtD
Eplerenone—Shock—Doxorubicin—thyroid cancer	0.000376	0.000906	CcSEcCtD
Eplerenone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000375	0.000904	CcSEcCtD
Eplerenone—Insomnia—Epirubicin—thyroid cancer	0.000374	0.000901	CcSEcCtD
Eplerenone—NR3C2—Preimplantation Embryo—TCF7L1—thyroid cancer	0.000372	0.0927	CbGpPWpGaD
Eplerenone—Skin disorder—Doxorubicin—thyroid cancer	0.000371	0.000895	CcSEcCtD
Eplerenone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000369	0.000891	CcSEcCtD
Eplerenone—Dyspnoea—Epirubicin—thyroid cancer	0.000368	0.000888	CcSEcCtD
Eplerenone—Dyspepsia—Epirubicin—thyroid cancer	0.000364	0.000877	CcSEcCtD
Eplerenone—Hypotension—Doxorubicin—thyroid cancer	0.000357	0.000861	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000357	0.00086	CcSEcCtD
Eplerenone—Fatigue—Epirubicin—thyroid cancer	0.000356	0.000858	CcSEcCtD
Eplerenone—Pain—Epirubicin—thyroid cancer	0.000353	0.000851	CcSEcCtD
Eplerenone—Constipation—Epirubicin—thyroid cancer	0.000353	0.000851	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000348	0.000839	CcSEcCtD
Eplerenone—Insomnia—Doxorubicin—thyroid cancer	0.000346	0.000833	CcSEcCtD
Eplerenone—Dyspnoea—Doxorubicin—thyroid cancer	0.000341	0.000821	CcSEcCtD
Eplerenone—Feeling abnormal—Epirubicin—thyroid cancer	0.00034	0.000821	CcSEcCtD
Eplerenone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000338	0.000814	CcSEcCtD
Eplerenone—Dyspepsia—Doxorubicin—thyroid cancer	0.000336	0.000811	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00033	0.000795	CcSEcCtD
Eplerenone—Fatigue—Doxorubicin—thyroid cancer	0.000329	0.000794	CcSEcCtD
Eplerenone—Constipation—Doxorubicin—thyroid cancer	0.000327	0.000788	CcSEcCtD
Eplerenone—Pain—Doxorubicin—thyroid cancer	0.000327	0.000788	CcSEcCtD
Eplerenone—Abdominal pain—Epirubicin—thyroid cancer	0.000326	0.000787	CcSEcCtD
Eplerenone—Body temperature increased—Epirubicin—thyroid cancer	0.000326	0.000787	CcSEcCtD
Eplerenone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000315	0.000759	CcSEcCtD
Eplerenone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000312	0.000753	CcSEcCtD
Eplerenone—Body temperature increased—Doxorubicin—thyroid cancer	0.000302	0.000728	CcSEcCtD
Eplerenone—Abdominal pain—Doxorubicin—thyroid cancer	0.000302	0.000728	CcSEcCtD
Eplerenone—Asthenia—Epirubicin—thyroid cancer	0.000296	0.000714	CcSEcCtD
Eplerenone—CYP11B2—Endogenous sterols—RXRA—thyroid cancer	0.000293	0.0731	CbGpPWpGaD
Eplerenone—Pruritus—Epirubicin—thyroid cancer	0.000292	0.000704	CcSEcCtD
Eplerenone—Diarrhoea—Epirubicin—thyroid cancer	0.000283	0.000681	CcSEcCtD
Eplerenone—Asthenia—Doxorubicin—thyroid cancer	0.000274	0.000661	CcSEcCtD
Eplerenone—Dizziness—Epirubicin—thyroid cancer	0.000273	0.000658	CcSEcCtD
Eplerenone—Pruritus—Doxorubicin—thyroid cancer	0.00027	0.000652	CcSEcCtD
Eplerenone—Vomiting—Epirubicin—thyroid cancer	0.000263	0.000633	CcSEcCtD
Eplerenone—Diarrhoea—Doxorubicin—thyroid cancer	0.000261	0.00063	CcSEcCtD
Eplerenone—Rash—Epirubicin—thyroid cancer	0.00026	0.000628	CcSEcCtD
Eplerenone—Dermatitis—Epirubicin—thyroid cancer	0.00026	0.000627	CcSEcCtD
Eplerenone—Headache—Epirubicin—thyroid cancer	0.000259	0.000624	CcSEcCtD
Eplerenone—Dizziness—Doxorubicin—thyroid cancer	0.000253	0.000609	CcSEcCtD
Eplerenone—Nausea—Epirubicin—thyroid cancer	0.000245	0.000591	CcSEcCtD
Eplerenone—Vomiting—Doxorubicin—thyroid cancer	0.000243	0.000586	CcSEcCtD
Eplerenone—Rash—Doxorubicin—thyroid cancer	0.000241	0.000581	CcSEcCtD
Eplerenone—Dermatitis—Doxorubicin—thyroid cancer	0.000241	0.00058	CcSEcCtD
Eplerenone—Headache—Doxorubicin—thyroid cancer	0.000239	0.000577	CcSEcCtD
Eplerenone—Nausea—Doxorubicin—thyroid cancer	0.000227	0.000547	CcSEcCtD
Eplerenone—CYP11B2—Metapathway biotransformation—CHST14—thyroid cancer	0.000199	0.0495	CbGpPWpGaD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00019	0.0473	CbGpPWpGaD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000136	0.0339	CbGpPWpGaD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00012	0.0299	CbGpPWpGaD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00011	0.0275	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000107	0.0266	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CHST14—thyroid cancer	8.42e-05	0.021	CbGpPWpGaD
Eplerenone—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	8.13e-05	0.0203	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—THRB—thyroid cancer	7.71e-05	0.0192	CbGpPWpGaD
Eplerenone—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	6.9e-05	0.0172	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.23e-05	0.0155	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	6.09e-05	0.0152	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—RXRA—thyroid cancer	5.86e-05	0.0146	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	5.77e-05	0.0144	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—TRIM33—thyroid cancer	5.13e-05	0.0128	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—MEN1—thyroid cancer	4.89e-05	0.0122	CbGpPWpGaD
Eplerenone—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	4.87e-05	0.0121	CbGpPWpGaD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.68e-05	0.0117	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—MINPP1—thyroid cancer	4.31e-05	0.0107	CbGpPWpGaD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	4.17e-05	0.0104	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—THRB—thyroid cancer	3.71e-05	0.00926	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NDUFA13—thyroid cancer	3.66e-05	0.00913	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CHST14—thyroid cancer	3.44e-05	0.00859	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.38e-05	0.00844	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—RXRA—thyroid cancer	3.27e-05	0.00817	CbGpPWpGaD
Eplerenone—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	3.21e-05	0.008	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	2.83e-05	0.00706	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—HPGD—thyroid cancer	2.77e-05	0.00692	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—TPR—thyroid cancer	2.51e-05	0.00625	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—RXRA—thyroid cancer	2.49e-05	0.0062	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MEN1—thyroid cancer	2.36e-05	0.00588	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.25e-05	0.00561	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—PPARG—thyroid cancer	2.07e-05	0.00516	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.94e-05	0.00484	CbGpPWpGaD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.93e-05	0.00481	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—MINPP1—thyroid cancer	1.83e-05	0.00455	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—RXRA—thyroid cancer	1.8e-05	0.00448	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—TPR—thyroid cancer	1.59e-05	0.00397	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—RXRA—thyroid cancer	1.58e-05	0.00393	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.57e-05	0.00392	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PRKAR1A—thyroid cancer	1.57e-05	0.00391	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NDUFA13—thyroid cancer	1.55e-05	0.00387	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CHST14—thyroid cancer	1.46e-05	0.00364	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.42e-05	0.00354	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—MINPP1—thyroid cancer	1.32e-05	0.00329	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—SLC5A5—thyroid cancer	1.19e-05	0.00298	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—HPGD—thyroid cancer	1.18e-05	0.00293	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NDUFA13—thyroid cancer	1.12e-05	0.0028	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.12e-05	0.00279	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CHST14—thyroid cancer	1.06e-05	0.00263	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—RXRA—thyroid cancer	1e-05	0.0025	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—PPARG—thyroid cancer	9.95e-06	0.00248	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.75e-06	0.00243	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HPGD—thyroid cancer	8.5e-06	0.00212	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	8.35e-06	0.00208	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—TPR—thyroid cancer	6.76e-06	0.00169	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	6.65e-06	0.00166	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PPARG—thyroid cancer	6.33e-06	0.00158	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MINPP1—thyroid cancer	6.14e-06	0.00153	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	5.22e-06	0.0013	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC5A5—thyroid cancer	5.06e-06	0.00126	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTGS2—thyroid cancer	4.98e-06	0.00124	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CHST14—thyroid cancer	4.91e-06	0.00122	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—TPR—thyroid cancer	4.88e-06	0.00122	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	4.81e-06	0.0012	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTEN—thyroid cancer	4.34e-06	0.00108	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—RXRA—thyroid cancer	4.25e-06	0.00106	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HPGD—thyroid cancer	3.95e-06	0.000986	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—AKT1—thyroid cancer	3.94e-06	0.000982	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC5A5—thyroid cancer	3.66e-06	0.000912	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—RXRA—thyroid cancer	3.07e-06	0.000766	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PPARG—thyroid cancer	2.68e-06	0.000669	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—AKT1—thyroid cancer	2.5e-06	0.000624	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TPR—thyroid cancer	2.27e-06	0.000566	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.23e-06	0.000557	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTGS2—thyroid cancer	2.11e-06	0.000527	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PPARG—thyroid cancer	1.94e-06	0.000484	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTEN—thyroid cancer	1.84e-06	0.000459	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.7e-06	0.000424	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.53e-06	0.000381	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—RXRA—thyroid cancer	1.43e-06	0.000356	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTEN—thyroid cancer	1.33e-06	0.000332	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—AKT1—thyroid cancer	1.06e-06	0.000265	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PPARG—thyroid cancer	9.02e-07	0.000225	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AKT1—thyroid cancer	7.67e-07	0.000191	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTGS2—thyroid cancer	7.09e-07	0.000177	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTEN—thyroid cancer	6.19e-07	0.000154	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AKT1—thyroid cancer	3.57e-07	8.89e-05	CbGpPWpGaD
